METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO IMMUNOTHERAPEUTIC ANTIBODIES
The methods and compositions described herein address the need in the art by providing compositions and methods for a therapy with an antibody that is specifically targeted to and/or retained intra- or peri-tumorally, limiting systemic exposure and reducing side-effects. Accordingly, aspects of the...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
28.07.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The methods and compositions described herein address the need in the art by providing compositions and methods for a therapy with an antibody that is specifically targeted to and/or retained intra- or peri-tumorally, limiting systemic exposure and reducing side-effects. Accordingly, aspects of the disclosure relate to a composition comprising an immunotherapeutic antibody operatively linked to an extracellular matrix (ECM)-affinity peptide. An ECM-affinity peptide is one that has affinity for an extracellular matrix protein.
Los métodos y composiciones descritos en la presente abordan la necesidad en la técnica al proporcionar composiciones y métodos para una terapia con un anticuerpo que está específicamente dirigido y/o retenido intratumoralmente o peritumoralmente, limitando la exposición sistémica y reduciendo los efectos secundarios. Por consiguiente, los aspectos de la descripción se refieren a una composición que comprende un anticuerpo inmunoterapéutico ligado operativamente a un péptido de afinidad de matriz extracelular (MEC). Un péptido de afinidad de MEC es uno que tiene afinidad por una proteína de matriz extracelular. |
---|---|
Bibliography: | Application Number: MX20190012579 |